EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a New Portable Genetic Analyzer for Point‐of‐Care Molecular Genetics and Pharmacogenomics Analysis

Ioanna Poulida iD, Kariofyllis Karamperis iD, Ioanna Konstantina Routsi, Ioannis Sarris, George Mantzouranis, Vassilis Kostopoulos iD, Christina Mitropoulou iD, George P Patrinos iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/9614566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 12.07.2026. Verfasst von Ioanna Poulida und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Patras, Greece, u…. Hauptthemen laut MEDLINE: Point-of-Care Systems, Pharmacogenetics, Genetic Testing. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Patras.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional medicine is now moving from the “one‐size‐fits‐all” model toward personalized medicine, where diagnostic and therapeutic decisions are guided by the patient’s unique genetic profile. Recent advances in genomics and pharmacogenomics have facilitated the identification of genetic variants linked to disease susceptibility and progression, as well as variability in drug response. However, translating these findings into clinical practice remains challenging, primarily due to the high cost and sophisticated genetic analysis infrastructure, which is only available in centralized genetic laboratories. A newly developed Portable Genetic Analyzer (PortaGen) was designed for point‐of‐care molecular genetics and pharmacogenomics analysis and evaluated in this study. PortaGen integrates 3D‐printed parts and laptop‐based centralized software control, along with digital recording and storage of results to support decentralized genetic testing. The prototype portable device was validated in comparison with an established portable polymerase chain reaction (PCR) workstation that complies with current operational standards and a reference laboratory‐based method. Genotyping analysis was performed using ARMS‐PCR (Amplification Refractory Mutation System Polymerase Chain Reaction) to detect and analyze CYP2C19 genetic variants ( CYP2C19 ∗ 2; rs4244285 , and CYP2C19 ∗ 17 ; rs12248560 ), relevant to pharmacogenomics, as well as the HBB: c.93-21(G>A) genetic variant, the most common variant leading to β ‐thalassemia. Concordance in genotyping calls between the new device, the established portable workstation, and the reference method was assessed using percentage agreement and Cohen’s kappa coefficient, demonstrating consistently high concordance with statistically significant results (p < 0.05). These findings demonstrate that the new portable genotyping analyzer has improved throughput, visualization, and workflow efficiency into a suitcase‐sized, portable point‐of‐care molecular genetic analysis device, which holds promise to advance personalized medicine interventions in a scalable and affordable fashion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Point-of-Care SystemsPharmacogeneticsGenetic TestingHumansCytochrome P-450 CYP2C19Precision MedicineGenotypeRapid Diagnostic Tests

Stichwörter der Autor:innen

3D printingCYP2C19HBBmolecular diagnosticspersonalized medicinepharmacogenomicspoint-of-care (PoC)β-thalassemia

Substanzen

Cytochrome P-450 CYP2C19CYP2C19 protein, human

Autor:innen und Institutionen

  • School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Patras, Greece, upatras.gr.
  • The Golden Helix Foundation, London, UK.
  • Polytechnic School, Department of Mechanical Engineering and Aeronautics, University of Patras, Patras, Greece, upatras.gr.
  • Laboratory of Innovative Therapeutics and Personalized Medicine, Hellenic Pasteur Institute, Athens, Greece, pasteur.gr.
  • Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE, uaeu.ac.ae.
  • Clinical Bioinformatics Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Erasmus University Medical Center, Rotterdam, the Netherlands, erasmusmc.nl.

ORCID-Profile: Ioanna Poulida, Kariofyllis Karamperis, Vassilis Kostopoulos, Christina Mitropoulou, George P Patrinos

Förderung

  • University of Patras

Zitieren

APA

Poulida, I., Karamperis, K., Routsi, I. K., Sarris, I., Mantzouranis, G., Kostopoulos, V., Mitropoulou, C., & Patrinos, G. P. (2026). Development of a New Portable Genetic Analyzer for Point‐of‐Care Molecular Genetics and Pharmacogenomics Analysis. Human Mutation, 2026(1). https://doi.org/10.1155/humu/9614566

Vancouver

Poulida I, Karamperis K, Routsi IK, Sarris I, Mantzouranis G, Kostopoulos V, et al. Development of a New Portable Genetic Analyzer for Point‐of‐Care Molecular Genetics and Pharmacogenomics Analysis. Human Mutation. 2026;2026(1). doi:10.1155/humu/9614566

BibTeX
@article{Poulida2026,
  author = {Poulida, Ioanna and Karamperis, Kariofyllis and Routsi, Ioanna Konstantina and Sarris, Ioannis and Mantzouranis, George and Kostopoulos, Vassilis and Mitropoulou, Christina and Patrinos, George P},
  title = {Development of a New Portable Genetic Analyzer for Point‐of‐Care Molecular Genetics and Pharmacogenomics Analysis},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/9614566}
}
Kostenlos starten →